Literature DB >> 33288631

COVID-19 and APOL1: Understanding Disease Mechanisms through Clinical Observation.

David J Friedman1.   

Abstract

Entities:  

Keywords:  APOL1; COVID-19; collapsing glomerulopathy; transplantation

Mesh：

Substances：

Year:  2020        PMID： 33288631      PMCID： PMC7894672          DOI： 10.1681/ASN.2020111629

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  10 in total

1.  APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.

Authors:  Alex N Kasembeli; Raquel Duarte; Michèle Ramsay; Pulane Mosiane; Caroline Dickens; Thérèse Dix-Peek; Sophie Limou; Efe Sezgin; George W Nelson; Agnes B Fogo; Stewart Goetsch; Jeffrey B Kopp; Cheryl A Winkler; Saraladevi Naicker
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

2.  Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I.

Authors:  Benoit Vanhollebeke; Philippe Truc; Philippe Poelvoorde; Annette Pays; Prashant P Joshi; Ravindra Katti; Jean G Jannin; Etienne Pays
Journal:  N Engl J Med       Date:  2006-12-28       Impact factor: 91.245

3.  AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype.

Authors:  Huijuan Wu; Christopher P Larsen; Cesar F Hernandez-Arroyo; Muner M B Mohamed; Tiffany Caza; Moh'd Sharshir; Asim Chughtai; Liping Xie; Juan M Gimenez; Tyler A Sandow; Mark A Lusco; Haichun Yang; Ellen Acheampong; Ivy A Rosales; Robert B Colvin; Agnes B Fogo; Juan Carlos Q Velez
Journal:  J Am Soc Nephrol       Date:  2020-06-19       Impact factor: 10.121

4.  Kidney Biopsy Findings in Patients with COVID-19.

Authors:  Satoru Kudose; Ibrahim Batal; Dominick Santoriello; Katherine Xu; Jonathan Barasch; Yonatan Peleg; Pietro Canetta; Lloyd E Ratner; Maddalena Marasa; Ali G Gharavi; M Barry Stokes; Glen S Markowitz; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2020-07-17       Impact factor: 10.121

5.  Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.

Authors:  B I Freedman; B A Julian; S O Pastan; A K Israni; D Schladt; M D Gautreaux; V Hauptfeld; R A Bray; H M Gebel; A D Kirk; R S Gaston; J Rogers; A C Farney; G Orlando; R J Stratta; S Mohan; L Ma; C D Langefeld; P J Hicks; N D Palmer; P L Adams; A Palanisamy; A M Reeves-Daniel; J Divers
Journal:  Am J Transplant       Date:  2015-03-24       Impact factor: 8.086

6.  The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.

Authors:  B T Lee; V Kumar; T A Williams; R Abdi; A Bernhardy; C Dyer; S Conte; G Genovese; M D Ross; D J Friedman; R Gaston; E Milford; M R Pollak; A Chandraker
Journal:  Am J Transplant       Date:  2012-04-04       Impact factor: 8.086

7.  APOL1 and Kidney Disease: From Genetics to Biology.

Authors:  David J Friedman; Martin R Pollak
Journal:  Annu Rev Physiol       Date:  2019-11-11       Impact factor: 19.318

Review 8.  APOL1 Nephropathy: From Genetics to Clinical Applications.

Authors:  David J Friedman; Martin R Pollak
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-02       Impact factor: 8.237

9.  COVID-19-Associated Glomerular Disease.

Authors:  Aneesha A Shetty; Ibrahim Tawhari; Luisa Safar-Boueri; Nay Seif; Ameen Alahmadi; Richard Gargiulo; Vikram Aggarwal; Irtaza Usman; Sergey Kisselev; Ali G Gharavi; Yahspal Kanwar; Susan E Quaggin
Journal:  J Am Soc Nephrol       Date:  2020-11-19       Impact factor: 14.978

10.  Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.

Authors:  Brendan Nichols; Prachi Jog; Jessica H Lee; Daniel Blackler; Michael Wilmot; Vivette D'Agati; Glen Markowitz; Jeffrey B Kopp; Seth L Alper; Martin R Pollak; David J Friedman
Journal:  Kidney Int       Date:  2014-08-06       Impact factor: 10.612
  10 in total
  7 in total

1.  CKD: The burden of disease invisible to research funders.

Authors: 
Journal:  Nefrologia (Engl Ed)       Date:  2022 Jan-Feb

Review 2.  The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication.

Authors:  Qin Ning; Di Wu; Xiaojing Wang; Dong Xi; Tao Chen; Guang Chen; Hongwu Wang; Huiling Lu; Ming Wang; Lin Zhu; Junjian Hu; Tingting Liu; Ke Ma; Meifang Han; Xiaoping Luo
Journal:  Signal Transduct Target Ther       Date:  2022-02-23

Review 3.  COVID-19 Vasculopathy: Mounting Evidence of an Indirect Mechanism of Endothelial Injury.

Authors:  Roberto F Nicosia; Giovanni Ligresti; Nunzia Caporarello; Shreeram Akilesh; Domenico Ribatti
Journal:  Am J Pathol       Date:  2021-05-23       Impact factor: 4.307

4.  COVID-19 mortality among kidney transplant candidates is strongly associated with social determinants of health.

Authors:  Jesse D Schold; Kristen L King; S Ali Husain; Emilio D Poggio; Laura D Buccini; Sumit Mohan
Journal:  Am J Transplant       Date:  2021-04-08       Impact factor: 8.086

5.  Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study.

Authors:  Michael K Sullivan; Jennifer S Lees; Thomas M Drake; Annemarie B Docherty; Georgia Oates; Hayley E Hardwick; Clark D Russell; Laura Merson; Jake Dunning; Jonathan S Nguyen-Van-Tam; Peter Openshaw; Ewen M Harrison; J Kenneth Baillie; Malcolm G Semple; Antonia Ho; Patrick B Mark
Journal:  Nephrol Dial Transplant       Date:  2022-01-25       Impact factor: 5.992

6.  CKD: The burden of disease invisible to research funders.

Authors: 
Journal:  Nefrologia       Date:  2021-11-17       Impact factor: 2.033

7.  RICORS2040: the need for collaborative research in chronic kidney disease.

Authors:  Alberto Ortiz
Journal:  Clin Kidney J       Date:  2021-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.